Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 34.49M P/E - EPS this Y 21.40% Ern Qtrly Grth -
Income -14.38M Forward P/E -4.11 EPS next Y 17.50% 50D Avg Chg -15.00%
Sales 42.16M PEG - EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 0.87 EPS next 5Y - 52W High Chg -54.00%
Recommedations 1.50 Quick Ratio 2.50 Shares Outstanding 11.40M 52W Low Chg 62.00%
Insider Own 17.47% ROA -13.55% Shares Float 8.31M Beta 0.47
Inst Own 42.01% ROE -32.26% Shares Shorted/Prior 67.95K/41.61K Price 3.08
Gross Margin 50.06% Profit Margin -34.11% Avg. Volume 41,353 Target Price 8.00
Oper. Margin -35.76% Earnings Date May 9 Volume 4,305 Change -3.75%
About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LNSR Chatroom

User Image Stock_Titan Posted - 1 day ago

$LNSR LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 https://www.stocktitan.net/news/LNSR/lensar-to-report-first-quarter-2024-financial-results-on-thursday-joqprothhnfo.html

User Image Stock_Titan Posted - 1 day ago

$LNSR LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/LNSR/lensar-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-fpti8oe1p1mt.html

User Image RocketThief Posted - 04/15/24

$LNSR the day will come

User Image RallyRaider Posted - 04/08/24

$LNSR "Adox and the other investors will be hoping that Juhasz can repeat the success of his two previous ventures - IntraLase and LenSx. IntraLase, which developed a femtosecond laser approach to refractive vision correction, was acquired by Advanced Medical Optics for more than $800 million back in 2007, while LenSx and its femtosecond platform for cataract surgery (!!!) was sold to Alcon Laboratories for a similar amount in 2010."

User Image RallyRaider Posted - 04/08/24

$LNSR https://optics.org/news/15/4/2

User Image RallyRaider Posted - 04/08/24

$LNSR whats with the volume? company has cash, product is promising and will likely turn profitable? "The LENSAR is the only cataract laser that visualizes the surgical steps with the so-called 3-D SCI system. [...] This means that all structures of the eye are precisely determined at the moment of the operation and not just calculated. This offers you a plus in safety compared to many other systems." translated as per: https://augenchirurgie.clinic/ueber-uns/technik/lensar-laser

User Image RocketThief Posted - 04/08/24

$LNSR 💰 gimme

User Image Stock_Titan Posted - 1 month ago

$LNSR LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/LNSR/lensar-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-hgc7geydpunx.html

User Image RocketThief Posted - 03/25/24

$LNSR added again. Dare I say best R/R in small cap healthcare? 🤷‍♂️

User Image HypnoTrader Posted - 03/24/24

$LNSR true market cap is over $110 million. Count the money warrants.

User Image BioGem Posted - 03/24/24

$LNSR I have a small, long position and just add some after this dip, many positives unfolding: -With 19.4M sh o/s (Basic + Convertibles), the mkt cap of 68M is extremely undervalued, while: -Sales in 2024 are above 50M, with EV/S < 1. -Cash is at 24.5M and cash burn at less than 1M/Q. Mgt expects cash breakeven in mid 2025. -High insider ownership. -North Run Capital, whose only goal is stock price appreciation, owns a majority of the company + 2 BOD members = Strong activist effect. -Best tech in lasers and market share is expanding at the expense of all other players. -Yearly performance (21 to 22 to 23) of revenue, gross profit, EBIDTA, and op losses are all significantly improved. Catalysts: -Approvals in EU and Asia. Expected all in mid 2024. -Approval of the phaco (in addition to femto) technology in the ALLY machine in late 2024 = Expect a huge boost in adoption by ophthalmologists on that feature alone. $XBI $IBB

User Image RocketThief Posted - 03/22/24

$LNSR added today

User Image _StockTrader Posted - 03/20/24

Real-Time Stock Data $LNSR Price: 3.89 Volume: 16862 Market Cap: 44432916 PE Ratio: -4.587412 Powered by: OZSC

User Image IsabellaDC Posted - 03/15/24

I call this scan - less volatile because your ahead and the herd hasn't found them. $OXBR $EUDA $LNSR $KINS $HCMA and so on.

User Image Stocks4thought Posted - 03/15/24

$LNSR Maybe sight takes em out? $SGHT

User Image Stocks4thought Posted - 03/04/24

$LNSR What percent of sales are disposable vs system placement- are they still doing mostly financingggggg?

User Image Stocks4thought Posted - 03/04/24

$LNSR Working it girl$

User Image HypnoTrader Posted - 03/04/24

$lnsr. With warrants, share count is close to 20 million. True market cap is around $112 million. Cash burn lower then losses last 2 quarters as warrants have been in the money for significant periods of time and have been converted and sold.

User Image OpenOutcrier Posted - 03/04/24

$LNSR (+26.0% pre) LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update - BW https://ooc.bz/l/26883

User Image tradingtwenty Posted - 03/04/24

$LNSR has trended 5 times in the past 24 hours (based on 5 minute intervals). Latest article on Mar 04, 2024 07:00 AM: LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update Link: https://tradingtwenty.com/news/380896/lensar-reports-fourth-quarter-and-full-year-2023-results-and-provides-business-update

User Image Ninja_Tradez Posted - 03/04/24

📢 $LNSR - LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update https://newsfilter.io/a/4afe8843d269a7a8dc161e526306700b

User Image Tokenist Posted - 03/04/24

🚨EARNINGS ALERT🚨 Notable earnings released for today: Modiv $MDV: $-0.29 EPS vs $0.0277 est. / $12.3M Revenue vs $12.36M est Sea $SE: $-0.19 EPS vs $-0.0673 est. / $3.6B Revenue vs $3.57B est LENSAR $LNSR: $-0.35 vs $-0.224 est. / $12.1M Revenue vs $11.98M est

User Image DonCorleone77 Posted - 03/04/24

$LNSR Lensar reports Q4 EPS (35c), consensus (22c) Reports Q4 revenue $12.11M, consensus $12M. "Our strong performance throughout 2023 continued in the fourth quarter, resulting in total revenue up 18% over the fourth quarter of 2022, with full-year revenue increasing 19%. We significantly exceeded our 2023 target of 30 ALLY placements, with 15 systems placed in the fourth quarter alone, marking the highest number of installations in a quarter since ALLY's launch. We are confident that ALLY's superior performance and efficiency will continue to drive more widespread adoption, solidifying our position as a leader in next-generation femtosecond laser cataract surgery technology," said Nick Curtis, President and CEO of LENSAR. "Half of our 2023 ALLY installations were to new customers, and the vast majority of these 'new' LENSAR customers switched from competitive systems. With continued strong growth in mind, we are working toward securing additional regulatory approvals...."

User Image Stock_Titan Posted - 03/04/24

$LNSR LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update https://www.stocktitan.net/news/LNSR/lensar-reports-fourth-quarter-and-full-year-2023-results-and-wkcqf9gmwe3g.html

User Image Ninja_Tradez Posted - 2 months ago

📢 $LNSR - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://newsfilter.io/a/18a8aa8e62a981ccc2b9ea97fe73cbf6

User Image Stock_Titan Posted - 2 months ago

$LNSR LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/LNSR/lensar-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-u44x5obygy39.html

User Image Stock_Titan Posted - 02/26/24

$LNSR LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 https://www.stocktitan.net/news/LNSR/lensar-to-report-fourth-quarter-and-full-year-2023-financial-results-bqlhiv8x6awm.html

User Image JamesBragg985 Posted - 02/09/24

$LNSR LENSAR, Inc.'s impact in the medical technology and healthcare sector is significant. Concurrently, it's a good opportunity to assess the performance of STLNF and its potential influence on your investment decisions.

User Image LachlanLindon Posted - 02/08/24

$SLAB $LNSR $GFF Analyst price target for today[] https://live-alerts-stock-trades.daytrading.network

User Image Stocks4thought Posted - 02/07/24

$LNSR You keep on keeping on- https://www.youtube.com/watch?v=Plo5PywZKdA&ab_channel=Captain%26Tennille-Topic

Analyst Ratings
Lake Street Buy Mar 19, 24
BTIG Buy Nov 22, 21
SVB Leerink Outperform Feb 24, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Winer Gary M Director Director Nov 22 Buy 2.10 300 630 53,345 11/27/23
Winer Gary M Director Director Nov 15 Buy 2.14 1,500 3,210 53,045 11/17/23
Winer Gary M Director Director Nov 10 Buy 2.135 1,000 2,135 51,545 11/14/23
Winer Gary M Director Director Aug 10 Buy 3.63 1,705 6,189 50,545 08/14/23
WEISNER AIMEE S Director Director May 17 Buy 2.5 33,353 83,382 37,638 05/19/23
STAAB THOMAS R II Chief Financial Offi.. Chief Financial Officer Dec 06 Buy 3.16 2,752 8,696 135,131 12/07/22
Winer Gary M Director Director Nov 16 Buy 4.18 2,500 10,450 37,052 11/17/22
Winer Gary M Director Director Aug 17 Buy 6.05 5,000 30,250 34,552 08/22/22